CDISC and TransCelerate Announce New Standard for Breast Cancer


CDISC and TransCelerate announce new Therapuetic Area Standard for Breast Cancer, which allows for data to be shared among industry professionals.

CDISC and TransCelerate announce the availability of a new CDISC Therapeutic Area Standard for Breast Cancer. This standard has the ability to streamline the way clinical research is conducted so that data can be shared among clinicians, researchers and regulators worldwide.   Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.